Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 5056 AL 5070

Aducanumab for the treatment of Alzheimer's disease

Tagliapietra M.

Drugs Today (Barc). 2022 Oct;58(10):465-477. doi: 10.1358/dot.2022.58.10.3422314.

The Lymphatic System in Neurological Disease and Alzheimer's Disease. A Brief Editorial

Pappolla MA, Carare RO, Poeggeler B, Wisniewski T, Sambamurti K.

Curr Alzheimer Res. 2022;19(10):689-693. doi: 10.2174/1567205020666221028111517.

Amyloid beta and its naturally occurring N-terminal variants are potent activators of human and mouse formyl peptide receptor 1

Busch L, Al Taleb Z, Tsai YL, Nguyen VTT, Lu Q, Synatschke CV, Endres K, Bufe B.

J Biol Chem. 2022 Dec;298(12):102642. doi: 10.1016/j.jbc.2022.102642. Epub 2022 Oct 27.

Intestinal Flora Affect Alzheimer's Disease by Regulating Endogenous Hormones

Wu Y, Hang Z, Lei T, Du H.

Neurochem Res. 2022 Dec;47(12):3565-3582. doi: 10.1007/s11064-022-03784-w. Epub 2022 Oct 30.

Lycopene: Sojourn from kitchen to an effective therapy in Alzheimer's disease

Kapoor B, Gulati M, Rani P, Kochhar RS, Atanasov AG, Gupta R, Sharma D, Kapoor D.

Biofactors. 2023 Mar;49(2):208-227. doi: 10.1002/biof.1910. Epub 2022 Nov 1.

TREM2 and Microglia Contribute to the Synaptic Plasticity: from Physiology to Pathology

Yu CJ, Wang M, Li RY, Wei T, Yang HC, Yin YS, Mi YX, Qin Q, Tang Y.

Mol Neurobiol. 2023 Feb;60(2):512-523. doi: 10.1007/s12035-022-03100-1. Epub 2022 Nov 1.

Geriatric update 2022: Preventing Alzheimer disease and more

Morgan-Gouveia M, Drago K, Harris P, Sheffrin M.

Cleve Clin J Med. 2022 Nov 1;89(11):617-624. doi: 10.3949/ccjm.89a.21094.

The role of transforming growth factor β1 /Smad pathway in Alzheimer's disease inflammation pathology

Yang C, Xu P.

Mol Biol Rep. 2023 Jan;50(1):777-788. doi: 10.1007/s11033-022-07951-8. Epub 2022 Nov 1.

Brown adipose tissue and alzheimer's disease

Tayanloo-Beik A, Nikkhah A, Alaei S, Goodarzi P, Rezaei-Tavirani M, Mafi AR, Larijani B, Shouroki FF, Arjmand B.

Metab Brain Dis. 2023 Jan;38(1):91-107. doi: 10.1007/s11011-022-01097-z. Epub 2022 Nov 2.

Dietary fish oil increases catalase activity in patients with probable Alzheimer's disease

Torres-Mendoza BMG, Ortiz GG, Sánchez-Romero L, Delgado-Lara DLC, García Martínez MT, Mireles-Ramírez MA, Cruz Serrano JA, Pacheco Moisés FP.

Nutr Hosp. 2022 Dec 20;39(6):1364-1368. doi: 10.20960/nh.04153.

Microglial efferocytosis: Diving into the Alzheimer's disease gene pool

Romero-Molina C, Garretti F, Andrews SJ, Marcora E, Goate AM.

Neuron. 2022 Nov 2;110(21):3513-3533. doi: 10.1016/j.neuron.2022.10.015.

Fast and Accurate Amyloid Brain PET Quantification Without MRI Using Deep Neural Networks

Kang SK, Kim D, Shin SA, Kim YK, Choi H, Lee JS.

J Nucl Med. 2023 Apr;64(4):659-666. doi: 10.2967/jnumed.122.264414. Epub 2022 Nov 3.

Potential of astrocytes in targeting therapy for Alzheimer's disease

Bi W, Lei T, Cai S, Zhang X, Yang Y, Xiao Z, Wang L, Du H.

Int Immunopharmacol. 2022 Dec;113(Pt A):109368. doi: 10.1016/j.intimp.2022.109368. Epub 2022 Oct 29.

Validity and reliability of the Turkish version of the ALBA screening instrument for Lewy body dementia in older adults

Kaya D, Yesil Gurel BH, Akpinar Soylemez B, Dost FS, Dokuzlar O, Mutlay F, Ates Bulut E, Petek K, Golimstok AB, Isik AT.

Appl Neuropsychol Adult. 2024 Nov-Dec;31(6):1457-1462. doi: 10.1080/23279095.2022.2142793. Epub 2022 Nov 4.

Disease specific and nonspecific metabolic brain networks in behavioral variant of frontotemporal dementia

Rus T, Perovnik M, Vo A, Nguyen N, Tang C, Jamšek J, Šurlan Popović K, Grimmer T, Yakushev I, Diehl-Schmid J, Eidelberg D, Trošt M.

Hum Brain Mapp. 2023 Feb 15;44(3):1079-1093. doi: 10.1002/hbm.26140. Epub 2022 Nov 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias